Ruchit Shah

685 total citations
61 papers, 448 citations indexed

About

Ruchit Shah is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Economics and Econometrics. According to data from OpenAlex, Ruchit Shah has authored 61 papers receiving a total of 448 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Oncology, 15 papers in Pulmonary and Respiratory Medicine and 15 papers in Economics and Econometrics. Recurrent topics in Ruchit Shah's work include Economic and Financial Impacts of Cancer (14 papers), Prostate Cancer Treatment and Research (8 papers) and Health Systems, Economic Evaluations, Quality of Life (6 papers). Ruchit Shah is often cited by papers focused on Economic and Financial Impacts of Cancer (14 papers), Prostate Cancer Treatment and Research (8 papers) and Health Systems, Economic Evaluations, Quality of Life (6 papers). Ruchit Shah collaborates with scholars based in United States, Canada and Spain. Ruchit Shah's co-authors include Marc Botteman, Yi Yang, Young‐Min Kwon, Shelby Corman, Chizoba Nwankwo, Rahul Khanna, Jennifer Stephens, Elizabeth Pappadopulos, Roger S. McIntyre and John P. Bentley and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Ruchit Shah

52 papers receiving 440 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ruchit Shah United States 14 117 108 76 61 58 61 448
Dominique Lejeune United States 14 106 0.9× 129 1.2× 41 0.5× 56 0.9× 32 0.6× 64 570
Ṣẹ̀yẹ Abògúnr̀in United Kingdom 9 58 0.5× 99 0.9× 62 0.8× 64 1.0× 38 0.7× 31 426
Denise Dal Lago Italy 6 183 1.6× 108 1.0× 58 0.8× 27 0.4× 21 0.4× 9 500
Susan Hong United States 12 265 2.3× 49 0.5× 62 0.8× 46 0.8× 63 1.1× 24 583
Karen Lin United States 13 212 1.8× 117 1.1× 28 0.4× 54 0.9× 85 1.5× 22 612
Kelly McQuarrie United States 13 97 0.8× 319 3.0× 46 0.6× 42 0.7× 80 1.4× 33 634
Ju‐Whei Lee United States 8 266 2.3× 107 1.0× 42 0.6× 27 0.4× 32 0.6× 10 457
Clizia Zichi Italy 12 140 1.2× 140 1.3× 31 0.4× 19 0.3× 47 0.8× 38 432
Filipa Fontes Portugal 17 396 3.4× 199 1.8× 40 0.5× 43 0.7× 41 0.7× 42 682
David Espinoza Australia 13 95 0.8× 69 0.6× 18 0.2× 81 1.3× 57 1.0× 47 533

Countries citing papers authored by Ruchit Shah

Since Specialization
Citations

This map shows the geographic impact of Ruchit Shah's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ruchit Shah with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ruchit Shah more than expected).

Fields of papers citing papers by Ruchit Shah

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ruchit Shah. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ruchit Shah. The network helps show where Ruchit Shah may publish in the future.

Co-authorship network of co-authors of Ruchit Shah

This figure shows the co-authorship network connecting the top 25 collaborators of Ruchit Shah. A scholar is included among the top collaborators of Ruchit Shah based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ruchit Shah. Ruchit Shah is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Goebell, Peter J., et al.. (2024). Real-world treatment of metastatic hormone-sensitive prostate cancer in the USA, Europe and Asia. Future Oncology. 20(14). 903–918. 15 indexed citations
2.
3.
Kersten, Marie José, Ruchit Shah, Caitlyn T. Solem, et al.. (2023). Quality-Adjusted Time without Symptoms or Toxicity: Analysis of Axicabtagene Ciloleucel versus Standard of Care in Patients with Relapsed/Refractory Large B Cell Lymphoma. Transplantation and Cellular Therapy. 29(5). 335.e1–335.e8. 3 indexed citations
4.
Shah, Ruchit, et al.. (2023). Calcaneal Osteosarcoma: A Rare Instance in Adolescent Patient. Journal of Orthopaedic Case Reports. 13(10). 168–173.
5.
6.
Nwankwo, Chizoba, et al.. (2022). Treatment Patterns and Economic Burden Among Newly Diagnosed Cervical and Endometrial Cancer Patients. Future Oncology. 18(8). 965–977. 9 indexed citations
7.
8.
Armbrecht, Eric S., Ruchit Shah, Elizabeth Pappadopulos, et al.. (2020). Economic and humanistic burden associated with noncommunicable diseases among adults with depression and anxiety in the United States. Journal of Medical Economics. 23(9). 1032–1042. 32 indexed citations
9.
Shah, Ruchit, Chizoba Nwankwo, Young‐Min Kwon, & Shelby Corman. (2020). Economic and Humanistic Burden of Cervical Cancer in the United States: Results from a Nationally Representative Survey. Journal of Women s Health. 29(6). 799–805. 20 indexed citations
10.
Shah, Ruchit, et al.. (2020). A rare case report on chronic osteomyelitis of fibula in a child of 6 years. Indian Journal of Orthopaedics Surgery. 5(4). 287–291. 1 indexed citations
11.
Shah, Ruchit, et al.. (2019). Treatment Characteristics for Nonmetastatic Castration-Resistant Prostate Cancer in the United States, Europe and Japan. Future Oncology. 15(35). 4069–4081. 9 indexed citations
12.
Strand, Vibeke, et al.. (2019). Economic burden of fatigue or morning stiffness among patients with rheumatoid arthritis: a retrospective analysis from real-world data. Current Medical Research and Opinion. 36(1). 161–168. 8 indexed citations
13.
14.
15.
Shah, Ruchit, Marc Botteman, Caitlyn T. Solem, et al.. (2019). A Quality-adjusted Time Without Symptoms or Toxicity (Q-TWiST) Analysis of Nivolumab Versus Everolimus in Advanced Renal Cell Carcinoma (aRCC). Clinical Genitourinary Cancer. 17(5). 356–365.e1. 11 indexed citations
16.
17.
Shah, Ruchit, Benjamin F. Banahan, Erin R. Holmes, et al.. (2018). An evaluation of the psychometric properties of the sf-12v2 health survey among adults with hemophilia. Health and Quality of Life Outcomes. 16(1). 229–229. 16 indexed citations
18.
19.
Joshi, Namita, Rahul Khanna, & Ruchit Shah. (2014). The Association Between Depression, Health-Related Quality Of Life (Hrqol), And Disability Status Among Adults With Arthritis. Value in Health. 17(3). A52–A52. 1 indexed citations
20.
Shah, Ruchit, et al.. (2012). PMS15 Cost Analysis of Febuxostat Versus Allopurinol for Prophylaxis of Gout Flares. Value in Health. 15(4). A36–A36. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Dominique Lejeune Breakdown of academic impact, for papers by Ṣẹ̀yẹ Abògúnr̀in Breakdown of academic impact, for papers by Denise Dal Lago Breakdown of academic impact, for papers by Susan Hong Breakdown of academic impact, for papers by Karen Lin Breakdown of academic impact, for papers by Kelly McQuarrie Breakdown of academic impact, for papers by Ju‐Whei Lee Breakdown of academic impact, for papers by Clizia Zichi Breakdown of academic impact, for papers by Filipa Fontes Breakdown of academic impact, for papers by David Espinoza
Rankless by CCL
2026